Chromosomal Crossover News and Research

RSS

Definite link between migraine and menstruation

Two new studies shows a definite link between migraine and menstruation. Approximately half of all women who seek clinical treatment for migraines have reported an association between migraine and menstruation, and a recent study by the City of London Migraine Clinic confirms their experience.

26 Jul 2004

Gene responsible for infertility

A paper describing discoveries about the role of a gene that is important in all animals, plants, and fungi is published in the 20 July 2004 issue of the journal Proceedings of the National Academy of Sciences.

23 Jul 2004

Radial artery appears to be a safe alternative to femoral artery for catheter procedures

Instead of threading catheters from the femoral artery in the groin, cardiologists can safely use the radial artery in the arm to gain access to coronary arteries for angioplasty, stent placement, and other procedures

22 Jul 2004

Cannabis extract helps reduce pain in multiple sclerosis patients

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial, BMJ Online First.

17 Jul 2004

New research offers clues into how the body controls appetite and food intake

Concurrent with the national obesity epidemic has been a rise in the discoveries about how the body controls appetite and food intake.

30 Jun 2004

Treatment with Strattera makes children with ADHD fall asleep faster

Twice daily treatment with Strattera® (atomoxetine HCl), approved for the treatment of attention-deficit/hyperactivity disorder (ADHD), showed children with ADHD fell asleep faster compared to three-times daily treatment with methylphenidate

29 Jun 2004

Opuntia ficus indica, a type of prickly pear cactus reduces hangover symptoms

Everyone knows a sure the way to avoid a hangover is to abstain from drinking alcoholic beverages, or at least to drink without over-indulging.

29 Jun 2004

Pharmaxis completes interim analysis on Bronchitol study

Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.

21 Jun 2004

Trial to beat cholesterol with soy and dairy combo

Researchers in the joint Adelaide Uni / UniSA Nutritional Physiology Research Group are looking for people to take part in a trial to see if combination low-fat dairy and soy foods will have an impact on reducing cholesterol and be more appealing to consumers.

3 Jun 2004

Incentive-based program in Mexico is appears to have improved child health

An incentive-based program that now reaches 4.5 million families in Mexico is associated with lowering the rate of anemia and improving growth in low-income, rural infants and children, according to a study in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.

1 Jun 2004

Enteric-coated aspirin is less potent than plain aspirin

Enteric-coated aspirin is less potent than plain aspirin, which may make it less effective in preventing heart disease, according to a preliminary small study presented today at the American Heart Association’s 5th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.

19 May 2004

Dark chocolate and cocoa may help arterial stiffness

“This is the first study to investigate whether chocolate has any favorable effects on cardiovascular function in healthy subjects,” says Charalambos Vlachopoulos, MD, of the Athens Medical School, Athens, Greece. “We found dark chocolate improves endothelial function and decreases arterial stiffness in healthy young adults.”

19 May 2004

The world generic drug market is expected to grow 10-15% annually

Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.

6 May 2004

Study finds malaria drug does not affect the ability of airline crew to perform their duties

Results from a new study presented today at the 75th Annual Scientific Meeting of the Aerospace Medical Association (AsMA) in Anchorage, USA, suggest that MalaroneTM (atovaquone and proguanil hydrochloride) would not be expected to affect the ability of pilots and cabin crew to perform their duties while on an aircraft.

6 May 2004

New information on genetic shuffling before egg or sperm formation rewrites genetic theory

Key decisions in the genetic shuffling that occurs before eggs or sperm are formed are made earlier than thought, rewriting textbook genetics, according to recent papers from researchers at UC Davis, Harvard University and UC San Diego.

16 Apr 2004

Oral sildenafil improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension

Oral sildenafil (Viagra®) improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension, according to the results of the first randomized, placebo-controlled, double-blind, crossover study, reported in the April 7, 2004 issue of the Journal of the American College of Cardiology.

6 Apr 2004

Walnuts prevent heart disease

A new clinical study shows that substituting walnuts for monounsaturated fat in a Mediterranean diet improves, and even restores, endothelial function (the property of arteries to dilate in order to meet an increased demand of blood, for instance due to a physical effort). Walnuts also reduce harmful cell adhesion molecules which are associated with atherosclerosis, commonly known as hardening of the arteries. These dual effects enhance the circulatory system, therefore aiding in the prevention of heart disease.

23 Mar 2004

Forward step in treatment of Allergic Rhinitis

Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company’s lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.

22 Mar 2004